Skip to main content

Table 3 Clinical outcomes

From: A worldwide multicentre evaluation of the influence of deterioration or improvement of acute kidney injury on clinical outcome in critically ill patients with and without sepsis at ICU admission: results from The Intensive Care Over Nations audit

 

Sepsis (n = 1946)

No sepsis (n = 6024)

No AKI (n = 628)

Stage 1 (n = 575)

Stage 2 (n = 219)

Stage 3 (n = 524)

No AKI (n = 2615)

Stage 1 (n = 1976)

Stage 2 (n = 627)

Stage 3 (n = 806)

ICU LOS (days), median (IQR)

7 (2–22)b

7 (3–29)b

8 (4–54)ab

19 (6–60)ab

3 (1–5)

3 (2–5)

2 (1–6)a

4 (2–60)a

Hospital LOS (days), median (IQR)

25 (12–60)b

28 (13–60)b

49 (14–60)ab

60 (22–60)ab

10 (6–22)

10 (6–24)

11 (6–35)a

20 (7–60)a

RRT, n (%)

25 (4.0)b

33 (5.7)b

15 (6.8)b

307 (58.6)ab

27 (1.0)

22 (1.1)

10 (1.6)

267 (33.1)a

ICU mortality, n (%)

108 (17.6)b

117 (20.6)ab

50 (23.5)ab

216 (41.5)ab

213 (8.4)

138 (7.2)

76 (12.4)a

228 (29.2)a

Hospital mortality, n (%)

154 (25.9)b

162 (29.3)ab

74 (35.6)ab

261 (51.7)ab

286 (11.8)

219 (11.9)

102 (17.4)a

262 (34.6)a

  1. AKI acute kidney injury, ICU intensive care unit, LOS length of stay, IQR interquartile range, RRT renal replacement therapy, n number of patients
  2. aSignificant at 5% level vs No AKI in the same group (sepsis or no sepsis)
  3. bSignificant at 5% level vs no sepsis patients with the same AKIN stage